Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Q4 2018 Earnings Conference Call March 12, 2019 8:30 AM ET Company Participants Ted Jenkins - Senior Director of IR and Corporate Communications Yuval Cohen - CEO Sean Moran - CFO Barbara White - Chief Medical Officer Craig Millian - Chief Commercial Officer Conference Call Participants Liisa Bayko - JMP Securities Brian Abrahams - RBC Capital Markets George Zavoico - B. Riley FBR Operator Greetings, and welcome to the Corbus Pharmaceuticals Quarterly Upda ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2018 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ________ TO ________. COMMISSION FILE NUMBER: 001-37348 Corbus Pharmaceuticals Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 46-4348039 (Sta ...